trial

Neurobiological Effects of Oxytocin in Schizophrenia

NCTId NCT04177719
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 44 (estimated)
Sponsored by National Institute of Mental Health and Neuro Sciences, India
Primary completion 2022-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
44 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Sequential
Masking
Double
Start
2019-11-08
Primary completion
2022-04
Eligibility
MALE · 18 Years · 45 Years

Interventions & indications

Drugs
Oxytocin

Sponsors

National Institute of Mental Health and Neuro Sciences, IndiaLead Sponsor

Sites

1 total
Bangalore, India

Facts & assertions

4 sourced
Enrollment
44
Phase
NA
Primary Completion Date
2022-04
Status
UNKNOWN
relationships
The graph out of here
drug
Oxytocin
drug
lead_sponsor
National Institute of Mental Health and Neuro Sciences, India
company
indication
Schizophrenia
indication
Schizophrenia
indication